Diabetes in COVID-19: Management

Authors

  • Shruti Brahmbhatt1 *, Vihang Brahmbhatt2, Maulin Mehta3 , Tejas Shah4

DOI:

https://doi.org/10.37506/ijfmt.v15i1.13694

Keywords:

COVID-19, Diabetes

Abstract

The COVID-19 (Corona Virus Disease-19) has become the most critical health problem worldwide. It was
first started from Wuhan, China and now it has affected more than 230 countries and millions of people.
The diabetic patients with uncontrolled glycemic state for long term can result in many microvascular and
macrovascular complications. Hence they are most commonly affected individuals during COVID-19. In
this review we have briefed about the impact of COVID-19 in diabetes, the different pathophysioloy and
management of diabetes in this phase.

Author Biography

Shruti Brahmbhatt1 *, Vihang Brahmbhatt2, Maulin Mehta3 , Tejas Shah4

1
Associate Professor, Pharmacology, SBKS MI & RC, SVDU, Piparia, 2Paediatric Consultant, Kalrav Children
Hospital, Vadodara, 3Associate Professor, Pharmacology, SBKS MI & RC, SVDU, Piparia, 4Associate Professor,
Biochemistry, SBKS MI & RC, SVDU, Piparia

Published

2020-12-31

How to Cite

Shruti Brahmbhatt1 *, Vihang Brahmbhatt2, Maulin Mehta3 , Tejas Shah4. (2020). Diabetes in COVID-19: Management. Indian Journal of Forensic Medicine & Toxicology, 15(1), 1944-1947. https://doi.org/10.37506/ijfmt.v15i1.13694